Leyre Navarro-Núñez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Leyre Navarro-Núñez has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Vicente Vicente
Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, 30003 Murcia, Spain
14 shared publications - José Rivera
Servicio de Hematología, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-ISCIII, 30003 Murcia, Spain
13 shared publications - Constantino Martínez
Department of Hematology, Hospital Morales Meseguer, Centro Regional de Hemodonacion, University of Murcia, IMIB Pascual Parrilla, Murcia, Spain
12 shared publications - María Luisa Lozano
Servicio de Hematología, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación Universidad de Murcia, IMIB‐Pascual Parrilla Murcia Spain
12 shared publications - Javier Corral
University of Murcia, Murcia, Spain
5 shared publications - Stephen P. Watson
University of Birmingham
5 shared publications
Latest Publications
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S207-S208
OC-0272 Organ preservation in rectal cancer: the randomised STAR-TREC phase II trial
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S207-S208
OC-0272 Organ preservation in rectal cancer: the randomised STAR-TREC phase II trial
- 1 September 2012
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 10 (9) , 1887-1894
Protein kinase Cε and protein kinase Cθ double‐deficient mice have a bleeding diathesis
- 1 September 2012
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 10 (9) , 1887-1894
Protein kinase Cε and protein kinase Cθ double‐deficient mice have a bleeding diathesis
- 1 March 2012
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 10 (3) , 484-486
Podoplanin‐expressing inflammatory macrophages activate murine platelets via CLEC‐2
- 1 March 2012
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 10 (3) , 484-486
Podoplanin‐expressing inflammatory macrophages activate murine platelets via CLEC‐2
- Open Access
- 16 February 2012
- Published by American Society of Hematology in Blood
- Vol. 119 (7) , 1747-1756
CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development
The C-type lectin receptor CLEC-2 signals through a pathway that is critically dependent on the tyrosine kinase Syk. We show that homozygous loss of either protein results in defects in brain vascular and lymphatic development, lung inflation, and perinatal lethality. Furthermore, we find that conditional deletion of Syk in the hematopoietic lineage, or conditional deletion of CLEC-2 or Syk in the megakaryocyte/platelet lineage, also causes defects in brain vascular and lymphatic development, although the mice are viable. In contrast, conditional deletion of Syk in other hematopoietic lineages had no effect on viability or brain vasculature and lymphatic development. We show that platelets, but not platelet releasate, modulate the migration and intercellular adhesion of lymphatic endothelial cells through a pathway that depends on CLEC-2 and Syk. These studies found that megakaryocyte/platelet expression of CLEC-2 and Syk is required for normal brain vasculature and lymphatic development and that platelet CLEC-2 and Syk directly modulate lymphatic endothelial cell behavior in vitro.
- 16 February 2012
- Published by American Society of Hematology in Blood
- Vol. 119 (7) , 1747-1756
Open AccessCLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development
The C-type lectin receptor CLEC-2 signals through a pathway that is critically dependent on the tyrosine kinase Syk. We show that homozygous loss of either protein results in defects in brain vascular and lymphatic development, lung inflation, and perinatal lethality. Furthermore, we find that conditional deletion of Syk in the hematopoietic lineage, or conditional deletion of CLEC-2 or Syk in the megakaryocyte/platelet lineage, also causes defects in brain vascular and lymphatic development, although the mice are viable. In contrast, conditional deletion of Syk in other hematopoietic lineages had no effect on viability or brain vasculature and lymphatic development. We show that platelets, but not platelet releasate, modulate the migration and intercellular adhesion of lymphatic endothelial cells through a pathway that depends on CLEC-2 and Syk. These studies found that megakaryocyte/platelet expression of CLEC-2 and Syk is required for normal brain vasculature and lymphatic development and that platelet CLEC-2 and Syk directly modulate lymphatic endothelial cell behavior in vitro.
- Open Access
- 1 February 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (6) , 4107-4116
Syk-dependent Phosphorylation of CLEC-2
- 1 February 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (6) , 4107-4116
Open AccessSyk-dependent Phosphorylation of CLEC-2
- 1 January 2011
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 105 (05) , 855-863
Rare homozygous status of P43 β1-tubulin polymorphism causes alterations in platelet ultrastructure
Summary: β1-tubulin is the main constituent of the platelet marginal band and studies with deficient mice showed that it maintains discoid shape and it is required for normal platelet formation. TUBB1 Q43P polymorphism is associated with decreased β1-tubulin expression, diminished platelet reactivity, and partial loss of discoid shape in heterozygous carriers. However, to date no studies have been carried out on homozygous PP individuals. Our study included 19 subjects genotyped for TUBB1 Q43P polymorphism (4 QQ, 4 QP, and 2 PP). The two PP individuals were recruited after genotyping of 2073 individuals. Biochemical, microscopy, and molecular studies were performed. Real-time PCR showed ∼40% decrease in TUBB1 mRNA in the two PP individuals compared to four QQ subjects. Western blot analysis confirmed this reduction. Electron microscopy revealed a majority of normal discoid platelets in PP individuals, although platelets with loose, re-orientated or invaginated protofilaments, and an over-developed open canalicular system were observed. Such abnormalities were not observed in QQ subjects. Morphometric analyses showed no differences between PP and QQ individuals. Immunofluorescence confirmed the presence of a normal marginal band in a majority of platelets from PP subjects. Interestingly, both PP subjects had a 40% lower platelet count than QP and QQ. TUBB1 Q43P polymorphism in homozygosity mildly affects platelet ultrastructure and our data further suggest that high levels of β1-tubulin might not be critical to sustain platelet discoid shape.
- 1 January 2011
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 105 (05) , 855-863
Rare homozygous status of P43 β1-tubulin polymorphism causes alterations in platelet ultrastructure
Summary: β1-tubulin is the main constituent of the platelet marginal band and studies with deficient mice showed that it maintains discoid shape and it is required for normal platelet formation. TUBB1 Q43P polymorphism is associated with decreased β1-tubulin expression, diminished platelet reactivity, and partial loss of discoid shape in heterozygous carriers. However, to date no studies have been carried out on homozygous PP individuals. Our study included 19 subjects genotyped for TUBB1 Q43P polymorphism (4 QQ, 4 QP, and 2 PP). The two PP individuals were recruited after genotyping of 2073 individuals. Biochemical, microscopy, and molecular studies were performed. Real-time PCR showed ∼40% decrease in TUBB1 mRNA in the two PP individuals compared to four QQ subjects. Western blot analysis confirmed this reduction. Electron microscopy revealed a majority of normal discoid platelets in PP individuals, although platelets with loose, re-orientated or invaginated protofilaments, and an over-developed open canalicular system were observed. Such abnormalities were not observed in QQ subjects. Morphometric analyses showed no differences between PP and QQ individuals. Immunofluorescence confirmed the presence of a normal marginal band in a majority of platelets from PP subjects. Interestingly, both PP subjects had a 40% lower platelet count than QP and QQ. TUBB1 Q43P polymorphism in homozygosity mildly affects platelet ultrastructure and our data further suggest that high levels of β1-tubulin might not be critical to sustain platelet discoid shape.
- 2 August 2010
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 8 (10) , 2328-2332
CLEC‐2 is not required for platelet aggregation at arteriolar shear
- 2 August 2010
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 8 (10) , 2328-2332
CLEC‐2 is not required for platelet aggregation at arteriolar shear
- 1 March 2010
- Published by Elsevier in Fitoterapia
- Vol. 81 (2) , 75-80
Effect of quercetin on platelet spreading on collagen and fibrinogen and on multiple platelet kinases
- 1 March 2010
- Published by Elsevier in Fitoterapia
- Vol. 81 (2) , 75-80
Effect of quercetin on platelet spreading on collagen and fibrinogen and on multiple platelet kinases
- 28 October 2009
- Published by Wiley in British Journal of Pharmacology
- Vol. 158 (6) , 1548-1556
Differential effects of quercetin, apigenin and genistein on signalling pathways of protease‐activated receptors PAR1and PAR4in platelets
Background and purpose: The modulation by flavonoids of platelet responses induced by thrombin has been little investigated, and the antiplatelet activity, as well as possible inhibitory mechanisms of these compounds on thrombin signalling, has not yet been elucidated. We explored whether flavonoids affect platelet signalling pathways triggered by thrombin and by the selective activation of its protease‐activated receptors (PARs) 1 and 4, and analysed the antagonism of these polyphenols at thrombin receptors.Experimental approach: We investigated the effect of a range of polyphenolic compounds on platelet aggregation, 5‐HT secretion, intracellular calcium mobilization, protein kinase activity and tyrosine phosphorylation, triggered by thrombin and PAR agonist peptides (PAR‐APs). The ability of these flavonoids to bind to thrombin receptors was investigated by competitive radioligand binding assays using125I‐thrombin.Key results: Quercetin, apigenin and genistein impaired platelet aggregation, as well as 5‐HT release and calcium mobilization, induced by thrombin and PAR‐APs. Quercetin and apigenin were inhibitors of protein kinases, but genistein exhibited a minimal ability to suppress platelet phosphorylation. Binding assays did not establish any kind of interaction between thrombin receptors and any of the flavonoids tested.Conclusions and implications: Quercetin, apigenin and genistein did not inhibit thrombin responses by interacting with thrombin receptors, but by interfering with intracellular signalling. While inhibition by genistein may be a consequence of affecting calcium mobilization, subsequent platelet secretion and aggregation, for quercetin and apigenin, inhibition of kinase activation may also be involved in the impairment of platelet responses.
- 28 October 2009
- Published by Wiley in British Journal of Pharmacology
- Vol. 158 (6) , 1548-1556
Differential effects of quercetin, apigenin and genistein on signalling pathways of protease‐activated receptors PAR1and PAR4in platelets
Background and purpose: The modulation by flavonoids of platelet responses induced by thrombin has been little investigated, and the antiplatelet activity, as well as possible inhibitory mechanisms of these compounds on thrombin signalling, has not yet been elucidated. We explored whether flavonoids affect platelet signalling pathways triggered by thrombin and by the selective activation of its protease‐activated receptors (PARs) 1 and 4, and analysed the antagonism of these polyphenols at thrombin receptors.Experimental approach: We investigated the effect of a range of polyphenolic compounds on platelet aggregation, 5‐HT secretion, intracellular calcium mobilization, protein kinase activity and tyrosine phosphorylation, triggered by thrombin and PAR agonist peptides (PAR‐APs). The ability of these flavonoids to bind to thrombin receptors was investigated by competitive radioligand binding assays using125I‐thrombin.Key results: Quercetin, apigenin and genistein impaired platelet aggregation, as well as 5‐HT release and calcium mobilization, induced by thrombin and PAR‐APs. Quercetin and apigenin were inhibitors of protein kinases, but genistein exhibited a minimal ability to suppress platelet phosphorylation. Binding assays did not establish any kind of interaction between thrombin receptors and any of the flavonoids tested.Conclusions and implications: Quercetin, apigenin and genistein did not inhibit thrombin responses by interacting with thrombin receptors, but by interfering with intracellular signalling. While inhibition by genistein may be a consequence of affecting calcium mobilization, subsequent platelet secretion and aggregation, for quercetin and apigenin, inhibition of kinase activation may also be involved in the impairment of platelet responses.
- Open Access
- 10 June 2009
- Published by Wiley in British Journal of Haematology
- Vol. 146 (1) , 95-103
Genotype–phenotype relationship for six common polymorphisms in genes affecting platelet function from 286 healthy subjects and 160 patients with mucocutaneous bleeding of unknown cause
Polymorphisms affecting platelet receptors and intracellular proteins have been extensively studied in relation to their potential influence in thrombosis and haemorrhages. However, few reports have addressed their impact on platelet function, with contradictory results. Limitations of these studies include, among others, small number of patients, the platelet functional parameters analyzed and their known variability in the healthy population. We studied the effect of six polymorphisms [ITGB3 1565T > C (HPA‐1), GPIBA variable number tandem repeat and 524C > T (HPA‐2), ITGA2 807C > T, ADRA2A 1780A > G, and TUBB1 Q43P] on platelet function in 286 healthy subjects and their potential pathogenetic role in 160 patients with hereditary mucocutaneous bleeding of unknown cause. We found no effect of any of these polymorphisms on platelet aggregation, secretion, PFA‐100®, and thrombin generation in platelet rich plasma. Furthermore, patients and controls showed no significant differences in the frequency of any of these polymorphisms. Thus, our study demonstrated that polymorphisms in genes affecting platelet function do not influence significantly major platelet functions and appear irrelevant in the pathogenesis of bleeding disorders.
- 10 June 2009
- Published by Wiley in British Journal of Haematology
- Vol. 146 (1) , 95-103
Open AccessGenotype–phenotype relationship for six common polymorphisms in genes affecting platelet function from 286 healthy subjects and 160 patients with mucocutaneous bleeding of unknown cause
Polymorphisms affecting platelet receptors and intracellular proteins have been extensively studied in relation to their potential influence in thrombosis and haemorrhages. However, few reports have addressed their impact on platelet function, with contradictory results. Limitations of these studies include, among others, small number of patients, the platelet functional parameters analyzed and their known variability in the healthy population. We studied the effect of six polymorphisms [ITGB3 1565T > C (HPA‐1), GPIBA variable number tandem repeat and 524C > T (HPA‐2), ITGA2 807C > T, ADRA2A 1780A > G, and TUBB1 Q43P] on platelet function in 286 healthy subjects and their potential pathogenetic role in 160 patients with hereditary mucocutaneous bleeding of unknown cause. We found no effect of any of these polymorphisms on platelet aggregation, secretion, PFA‐100®, and thrombin generation in platelet rich plasma. Furthermore, patients and controls showed no significant differences in the frequency of any of these polymorphisms. Thus, our study demonstrated that polymorphisms in genes affecting platelet function do not influence significantly major platelet functions and appear irrelevant in the pathogenesis of bleeding disorders.